• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Biography

Jianling is a biochemist who has studied the cellular signalling pathways that involve mTOR, a master regulator of cell anabolism. He has built up a continuous track record based on mTOR-related publications, and has authored 40 peer-reviewed publications, including 18 first/last author papers in top-ranking journals; e.g. Curr BiolCell Mol Life Sci, DiabetologiaInt J CancerJ Biol ChemMol Cell BiolJ Mol Biol, among others. His articles has thus far been cited 1321 times (search date: 07/08/2020, Google Scholar). Most of these papers are related to protein synthesis/mRNA translation, tumour growth/survival/metastasis and pancreatic β-cell functions. He also hold two patents and authored two book chapters and has given 8 presentations at international conferences. He recently joint A/Prof. Luke Selth's lab at Flinders Centre for Innovation in Cancer and his research interests have now evolved towards studying the regulation of mRNA translation in prostate cancer progression.

Education/Academic qualification

University of Leicester, Leicester

Award Date: 13 Jul 2012

Keywords

  • RM Therapeutics. Pharmacology
  • biochemistry
  • physiology

Fingerprint

Dive into the research topics where Jianling Xie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.